Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension

• Published in: Clinical biochemistry Vol. 36; no. 7; pp. 575 - 578
• Main Authors: Cekmen, Mustafa Baki, Erbagci, Ayse Binnur, Balat, Ayse, Duman, Can, Maral, Hale, Ergen, Kivanc, Ozden, Meltem, Balat, Ozcan, Kuskay, Sevinc
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-10-2003
• Subjects: Adult; Case-Control Studies; Female; Humans; Hypertension - blood; Lipids - blood; Lipoproteins - blood; Malondialdehyde; Malondialdehyde - blood; Plasma lipids; Plasma lipoproteins; Pre-Eclampsia - blood; Preeclampsia; Pregnancy; Plasma lipoproteins; Preeclampsia; Plasma lipids; Malondialdehyde
• ISSN: 0009-9120; 1873-2933
• DOI: 10.1016/S0009-9120(03)00099-7

Aim of this study was to evaluate implication of pregnancy induced hypertension on maternal plasma lipid, lipoprotein, apolipoprotein concentrations and lipid peroxidation products by a comparison of normal pregnancy
vs. preeclampsia.
Thirty-four women with preeclampsia and 32 healthy pregnant women (controls) in the third trimester were recruited for this study.
In the preeclamptic group plasma total triglyceride, low density lipoprotein cholesterol (LDL-C), malondialdehyde (MDA) and apolipoprotein B (apo-B) were significantly increased, while plasma high density lipoprotein cholesterol (HDL-C) was significantly decreased compared to that of control group. There was no significant difference in total cholesterol and apolipoprotein A1 (apo-A1) concentrations.
Our findings suggest that preeclampsia share some metabolic characteristics with coronary artery disease such as dislipidemia and increased lipid peroxidation. However lipoprotein concentrations may be better biochemical markers of dislipidemia in the preeclamptic state than the corresponding apolipoproteins.